New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 30, 2014
07:01 EDTFLDMFluidigm price target raised to $47 from $28 at Cantor
Cantor increased its price target on Fluidigm after the company acquired privately held DVS Sciences. The firm thinks the deal further strengthens and diversifies Fluidigm's already highly capabilities in single-cell genomics, and leaves the company better positioned to accelerate market expansion for single-cell analysis. The firm keeps a Buy rating on the stock.
News For FLDM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 25, 2015
09:27 EDTFLDMLeerink life science tools analyst holds an analyst/industry conference call
Life Science Tools and Diagnostics Dan Leonard, along with Dr. Paul Robson and Dr. Peter Kuhn, discuss the demand for Fluidigm's single cell prep products, including the impact to Biomark and the utility of CyTOF on an Analyst/Industry conference call to be held on July 1 at 2 pm.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use